All In Biotech

Drug Trial Radar · NCT06949800

CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

Probiotics to Treat HSIL and Reduce Persistent High Risk HPV Infection in Women and Men Living With HIV

Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Sep 4, 2026

Primary completion

Oct 31, 2027

Study completion May 31, 2028

Sponsor

Lead sponsor
University of California, San FranciscoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Exegi Pharma, LLC; National Cancer Institute (NCI)
First posted
Apr 29, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population

Conditions

  • HSIL, High Grade Squamous Intraepithelial Lesion
  • HPV-Related Squamous Cell Carcinoma
  • Anal HSIL

Interventions

  • EXE-346 ProbioticDrug

    Given as a single-dose, powder packet to mix with water

  • PlaceboDrug

    Given as a single-dose, powder packet to mix with water

  • Usual Care High Resolution Anoscopy (HRA)Procedure

    Non-investigational HRA will be performed

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with no disease presentTime frame: Up to 36 weeks
  2. Proportion of participants reporting treatment-emergent adverse eventsTime frame: Up to 36 weeks

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California, San Francisco

    San Francisco, California · Recruiting

  • University of Puerto Rico Comprehensive Cancer Center

    San Juan, Puerto Rico, Puerto Rico · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.